Pfizer Raises Full-Year Forecast on New-Product Momentum
Pfizer raised its full-year guidance as momentum in new products offset declining sales of its Covid-19 vaccine and treatments.
By Kelly CloonanPfizer boosted its guidance for the year, as momentum in new products helped it offset declining sales for its Covid-19 vaccine and treatments.The New York company said Tuesday that sales for its recently launched and acquired products--which include cancer treatments Padcev and Lor…